Cheryl D. Coon, PhD

Cheryl D. Coon, PhD, is Vice President of the Clinical Outcome Assessment (COA) Program, overseeing the Patient-Reported Outcomes Consortium, the Electronic COA Consortium, and the Rare Disease COA Consortium. Dr. Coon is a psychometrician with two decades of experience developing and evaluating COAs for use in constructing patient-centered endpoints. Prior to joining C-Path, she was a consultant, advising sponsors on the use, analysis, and interpretation of COAs in clinical trials. Her experience includes the statistical analysis of COA endpoint data and the communication of psychometric and efficacy evidence to regulatory authorities and other stakeholders. Dr. Coon is a recognized thought-leader in the field of COAs and seeks to generate evidence that allows the benefits of new therapies to be clearly communicated to patients and clinicians for informing treatment decisions. After receiving a BA in Psychology and French at the University of North Carolina at Chapel Hill (UNC-CH), Dr. Coon remained at UNC-CH to earn an MA and a PhD in Quantitative Psychology, during which time her research focused on item response theory and included early work on the Patient-Reported Outcomes Measurement Information System.